← FDA Drug Approvals (Drugs@FDA)
REPATHA
BLA · Biologics License Application · Sponsor: AMGEN INC · Approved 2021-02-26
Drug application
- FDA Application #
BLA125522- Application type
- Biologics License Application
- Brand name
- REPATHA
- Generic name
- EVOLOCUMAB
- Active ingredients
- EVOLOCUMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- AMGEN INC
- Manufacturer
- Amgen USA Inc.
- First approval
- 2021-02-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown